UTSA Recruits Berkeley Administrator to Lead New Data School
govtech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from govtech.com Daily Mail and Mail on Sunday newspapers.
A year from opening, UT San Antonio s data school has new director
expressnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from expressnews.com Daily Mail and Mail on Sunday newspapers.
Ohio won’t reach herd immunity until November, and red states lag behind blue states, new research says Julie Washington, cleveland.com
CLEVELAND, Ohio If Ohio continues its current rate of COVID-19 vaccination, it could take until November to reach herd immunity, according to APM Research Lab, a nonprofit, nonpartisan organization that produces a weekly report about vaccination progress across the country.
And the nation’s political divide is reflected in its vaccination progress, APM found after analyzing federal data.
In general, vaccination rates are higher in states that voted for President Joe Biden, and lower in states that supported former President Donald Trump in the 2020 election.
Novel AI tool takes a DeepCE dive into potential drugs for COVID-19
5
A new phenotype-based compound screening technology, called DeepCE, identified 10 compounds that could be repurposed for COVID-19.
DeepCE (pronounced ‘Deep Sea’), a novel deep-learning computer model that can predict how gene expression will change in response to medicines, has been used to identify 10 compounds that could be repurposed as treatments for COVID-19.
Two of the drugs – cyclosporin, an immunosuppressant used to prevent transplant organ rejection, and anidulafungin, an antifungal agent – are currently approved for clinical use. The others are investigational and being evaluated in a wide range of indications, from hepatitis C and fungal disease to cancer and heart disease. According to the team, some of these candidates have already been evaluated in COVID-19 patients.